Teresa Bitetti – General Manager, BMS Canada
Teresa Bitetti has a long history with BMS, spanning 3 decades in which she rose up the ranks starting from Senior Director of Abilify Marketing before becoming Sales Vice President…
Pediapharm is the first and only speciality pharmaceutical corporation in Canada that exclusively distributes and licenses innovative medicines used to treat pathological conditions that mainly affect children from infancy to eighteen years of age.
Through its network with key stakeholders within the paediatric arena, Pediapharm’s key objective is to partner with leading healthcare entities around the world to bring innovative paediatric products to the Canadian market. By doing so, the company contributes to the improvement of children’s health and quality of life; its partners can thus be assured of long-term commitment and unwavering integrity.
Pediapharm’s unique business model, company values and human capital, set it apart as Canada’s leading paediatric speciality pharmaceutical company.
Contact:
Address: 1 Place du Commerce, Verdun, QC H3E 1A2 Montreal, Canada
Tel.: +1 514 762 2626
Website: http://www.pedia-pharm.com/en/
Teresa Bitetti has a long history with BMS, spanning 3 decades in which she rose up the ranks starting from Senior Director of Abilify Marketing before becoming Sales Vice President…
Mike Brogan, before taking up the mantle of President at IMS was VP of Business Integration at IMS for a year. Today, he talks about the difficulties he has come…
Dr. Fernand Labrie, long before becoming CEO of EndoCeutics, discovered and developed medical castration with GnRH agonists, a breakthrough treatment that quickly replaced surgical castration back in the early 1980s.…
Minister for Science shares with us how the Canadian Government has taken a different approach to funding innovationand the benefits it has reaped in the pharma industry as a whole…
Gary Goodyear, Minister for Science, shares with us how the Canadian Government has taken a different approach to funding innovation and the benefits it has reaped in the pharma industry…
You have been President of Rx&D since 2004, and have witnessed the market’s development over the years. What have been the most important issues since you started and what are…
See our Cookie Privacy Policy Here
